Biotech Bull Market Consolidation Phase-Profit Taking Picks Up.. St. Paddy’s Green Update 3/17
March 17 Update -GREEN DAY with Geopolitical risk on back burner As of 11.38a EDT Industrials lead up 1%, healthcare up 0.8%, IBB up 1.33% Biopharmaceuticals stocks were strong with Rayno large cap picks: Alexion (ALXN $117) up 1.45%, Amgen (AMGN $125) up 1.9%, Biogen Idec (BIIB $345) up 3.8%,...
Rayno Life Science Stocks Rally On A Choppy Day: ALXN, AMGN, BIIB, PCYC
Mini-Rally in Life Science Stocks--- Update 10p PDT Biotech stocks recovered off their am lows today with major ETFs (FBT,IBB,XBI ($161.45) up about 0.3% and within 5% of highs. Over the past week or so biopharma stocks have been weak with a "topping" process evident in late February....
Update: Sell-Off In Biopharmaceutical Stocks- BIIB, PCYC, REGN
Big Large Cap Winners Down-Volatilty Increasing ETFS: IBB $257 down 1.57%, PBE $45.25 down 1.2% , XBI $159.7 down 1.17% The profit taking which actually began last Friday and, after a brief recovery, resumed yesterday accelerating today. Large caps are leading the way down. Notable losers...
Clinical Diagnostic Companies 2013 Financial Metrics and Valuation Models
Diagnostics Companies-After 2013 Financial Reporting Stocks to Watch: Cepheid (CPHD), Exact Sciences (EXAS) , Orasure (OSUR) Price to Sales (P/S) is the best metric of value as many companies in the sector are not profitable. Molecular diagnostics and genomics are the strongest growth sectors...
Geopolitical Risk Deemed Minimal In Biotech… Update Sell-Off 3/6/14
Stealth Biotech Sell-Off-Caution Urged-Red Screen Aegerion (AEGR $50) down 7%, Medivation (MDVN $66.9) off 5%, Puma (PBYI $113.5) off 5.4%, IBB ($261.75) off 2.8% , XBI ($161.9 off 3% etc. ----------from 5/4-------- Most Biotech Stocks Recover From Two Day Sell-Off Stocks Surge After Ukraine...